AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2015
Jun 17, 2015
31046_dirs_2015-06-17_c92dfebd-4079-42c7-b1ad-da544b08ce4c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-06-17
Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-17 | Common Stock | M | 3500 | $10.85 | Acquired | 7276 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-17 | Stock Option (Right to Buy) | $10.85 | M | 3500 | Disposed | 2023-05-15 | Common Stock (3500) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $10.85 | 2023-05-15 | Common Stock (110694) | 110694 | Direct |
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (200000) | 200000 | Direct |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (300000) | 300000 | Direct |
| Stock Option (Right to Buy) | $218.4 | 2022-01-10 | Common Stock (416) | 416 | Direct |
| Stock Option (Right to Buy) | $490.8 | 2021-04-27 | Common Stock (541) | 541 | Direct |
| Stock Option (Right to Buy) | $1149.6 | 2020-02-02 | Common Stock (583) | 583 | Direct |
| Stock Option (Right to Buy) | $451.2 | 2019-05-15 | Common Stock (583) | 583 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-04-01 | Common Stock (293) | 293 | Direct |
| 2018-04-01 | $735.6 | 2018-01-25 | Common Stock (708) | 708 | Direct |
| Stock Option (Right to Buy) | $626.4 | 2017-04-18 | Common Stock (322) | 322 | Direct |
| Stock Option (Right to Buy) | $392.4 | 2016-03-01 | Common Stock (136) | 136 | Direct |
Footnotes
F1: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
F3: This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
F4: This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
F5: This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
F6: Currently exercisable.